3839 related articles for article (PubMed ID: 30194544)
21. The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder.
Sahli ZT; Banerjee P; Tarazi FI
Expert Opin Drug Discov; 2016; 11(5):515-23. PubMed ID: 26971593
[TBL] [Abstract][Full Text] [Related]
22. [Mechanism of action of antidepressant drugs: importance of genetically modified mice in the pharmacological in vivo approach].
Gardier A
Therapie; 2005; 60(5):469-76. PubMed ID: 16433012
[TBL] [Abstract][Full Text] [Related]
23. [The pharmacological basis of the serotonin system: Application to antidepressant response].
David DJ; Gardier AM
Encephale; 2016 Jun; 42(3):255-63. PubMed ID: 27112704
[TBL] [Abstract][Full Text] [Related]
24. [Neurobiology and pharmacotherapy of social phobia].
Aouizerate B; Martin-Guehl C; Tignol J
Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
[TBL] [Abstract][Full Text] [Related]
25. Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.
Stahl SM
J Clin Psychiatry; 1998; 59 Suppl 4():5-14. PubMed ID: 9554316
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy of atypical antipsychotics in depressive syndromes].
Quintin P; Thomas P
Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
[TBL] [Abstract][Full Text] [Related]
27. A risk-benefit assessment of mirtazapine in the treatment of depression.
Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
[TBL] [Abstract][Full Text] [Related]
28. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
Sánchez C; Hyttel J
Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
[TBL] [Abstract][Full Text] [Related]
30. Quetiapine : A Review of its Use in Schizophrenia.
Gunasekara NS; Spencer CM
CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
[TBL] [Abstract][Full Text] [Related]
31. Antidepressant nonadherence and sexual dysfunction among young adult males: the cross-sectional YAMAN study.
Rabinowitz MJ; Li O; Pil EH; Eaton CK; Kohn TP; Haney NM; Herati AS
World J Urol; 2024 May; 42(1):295. PubMed ID: 38709300
[TBL] [Abstract][Full Text] [Related]
32. Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies.
Artigas F; Bortolozzi A; Celada P
Eur Neuropsychopharmacol; 2018 Apr; 28(4):445-456. PubMed ID: 29174531
[TBL] [Abstract][Full Text] [Related]
33. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Gee MD; Krishen A; Wunderlich HP; Le Clus A; Evoniuk G; Modell JG
J Psychopharmacol; 2010 Aug; 24(8):1209-16. PubMed ID: 19939870
[TBL] [Abstract][Full Text] [Related]
34. [Vortioxetine in the treatment of major depression].
de Bartolomeis A; Fagiolini A; Maina G
Riv Psichiatr; 2016; 51(6):215-230. PubMed ID: 27996982
[TBL] [Abstract][Full Text] [Related]
35. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
36. [Interest of the use of pindolol in the treatment of depression: review].
Brousse G; Schmitt A; Chereau I; Eschalier A; Dubray C; Llorca PM
Encephale; 2003; 29(4 Pt 1):338-50. PubMed ID: 14615704
[TBL] [Abstract][Full Text] [Related]
37. Long-term administration of the antidepressant vilazodone modulates rat brain monoaminergic systems.
El Mansari M; Crnic A; Oosterhof C; Blier P
Neuropharmacology; 2015 Dec; 99():696-704. PubMed ID: 26362359
[TBL] [Abstract][Full Text] [Related]
38. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data.
Sanchez C; Asin KE; Artigas F
Pharmacol Ther; 2015 Jan; 145():43-57. PubMed ID: 25016186
[TBL] [Abstract][Full Text] [Related]
39. Mirtazapine: clinical overview.
Gorman JM
J Clin Psychiatry; 1999; 60 Suppl 17():9-13; discussion 46-8. PubMed ID: 10446735
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
